P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO) WITHOUT CYTOPENIAS

相似書籍

• Resolution of hypogammaglobulinemia-associated recurrent Campylobacter bacteraemia after hematopoietic cell transplantation (HCT)
  由: Emmanouil Karofylakis, MD, et al.
  出版: (2025-02-01)
• HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT) IN CHILDREN WITH AUTISM SPECTRUM DISORDER: CHALLENGES AND THERAPEUTIC STRATEGIES
  由: ASS Ibanez, et al.
  出版: (2024-10-01)
• Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia
  由: Mahesh Swaminathan, et al.
  出版: (2023-02-01)
• Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era
  由: María Queralt Salas, et al.
  出版: (2024-12-01)
• sMAdCAM‐1 is decreased after allo‐HCT, along with gut microbiota dysbiosis, and is associated with hematopoietic recovery
  由: Karen Fadel, et al.
  出版: (2025-01-01)